The pilot phase of the NIH chemical genomics center

Current Topics in Medicinal Chemistry

Volumn 9, Issue 13, 2009, Pages 1181-1193

  Thomas, Craig J ^a   Auld, Douglas S ^a   Huang, Ruili ^a   Huang, Wenwei ^a   Jadhav, Ajit ^a   Johnson, Ronald L ^a   Leister, William ^a   Maloney, David J ^a   Marugan, Juan J ^a   Michael, Sam ^a   Simeonov, Anton ^a   Southall, Noel ^a   Xia, Menghang ^a   Zheng, Wei ^a   Inglese, James ^a   Austin, Christopher P ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (1 CARBOXY 2 (NAPHTHALEN 1 YL)ETHYL) 1,3 DIOXOISOINDOLINE 5 CARBOXYLIC ACID; ACETANILIDE DERIVATIVE; BETA LACTAMASE AMPC; BETA LACTAMASE INHIBITOR; CARBOXYLIC ACID DERIVATIVE; CHAPERONE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ENZYME INHIBITOR; FIREFLY LUCIFERASE; FURAZOLIDONE; GLUCOSYLCERAMIDASE; GLUTATHIONE REDUCTASE INHIBITOR; HORMONE RECEPTOR BLOCKING AGENT; HORMONE RECEPTOR STIMULATING AGENT; N [4 (5 (3 BENZYL 4 OXO 1,2,3,4 TETRAHYDROQUINAZOLIN 2 YL) 2 METHOXYBENZYLOXY)PHENYL]ACETAMIDE; PHTHALIMIDE DERIVATIVE; TERTBUTYL 1 (5 (2 CHLORO 6 FLUOROBENZYLSULFONYL) 1,3,4 OXADIAZOL 2 YL) 2 METHYLPROPYLCARBAMATE; THYROTROPIN RECEPTOR; UNCLASSIFIED DRUG;

AUTOFLUORESCENCE; CHEMISTRY; CYTOTOXICITY; ENZYME INHIBITION; GENOMICS; HIGH THROUGHPUT SCREENING; HUMAN; MEDICAL RESEARCH; MOLECULAR LIBRARY; MOLECULE; NONHUMAN; REVIEW;

CHEMISTRY, PHARMACEUTICAL; DRUG EVALUATION, PRECLINICAL; GENOMICS; HIGH-THROUGHPUT SCREENING ASSAYS; NATIONAL INSTITUTES OF HEALTH (U.S.); PILOT PROJECTS; SMALL MOLECULE LIBRARIES; UNITED STATES;

EID: 74249111318     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802609789753644     Document Type: Review

References (50)

1. Inglese, J.; Auld, D. S. High throughput screening techniques: overview of applications in chemical biology. In: Wiley Encyclopedia of Chemical Biology; John Wiley & Sons, Inc., Hoboken, NJ, 2008.
2. Austin, C. P.; Brady, L. S.; Insel, T. R.; Collins, F. S. NIH molecular libraries initiative. Science 2004, 306, 1138-1139.
3. Inglese, J.; Johnson, R. L.; Simeonov, A.; Xia, M.; Zheng, W.; Austin, C. P.; Auld, D. S. High-throughput screening assays for the identification of chemical probes. Nat. Chem. Biol. 2007, 3, 466-479.
4. Inglese, J.; Auld, D. S.; Jadhav, A.; Johnson, R. L.; Simeonov, A.; Yasgar, A.; Zheng, W.; Austin, C. P. Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical libraries. Proc. Natl. Acad. Sci. USA 2006, 103, 11473-11478.
5. Auld, D. S.; Johnson, R. L.; Zhang, Y.-Q.; Veith, H.; Jadhav, A.; Yasgar, A.; Simeonov, A.; Zheng, W.; Martinez, E. D.; Westwick, J. K.; Austin, C. P.; Inglese, J. Fluorescent protein-based cellular assays analyzed by laser-scanning microplate cytometry in 1536-well plate format. Methods Enzymol. 2006, 414, 566-589.
6. Yasgar, A.; Shinn, P.; Jadhav, A., Auld, D., Michael, S.; Zheng, W.; Austin, C. P.; Inglese, J.; Simeonov, A. J. A. L. A. 2008, 79-89.
7. http://ncgc.nih.gov/docs/ has a link to "Enabling the Large Scale Analysis of Quantitative High Throughput Screening Data"
8. Kennedy, J. P.; Williams, L.; Bridges, T. M.; Daniels, R. N.; Weaver, D.; Lindsley, C. W. Application of combinatorial chemistry science on modern drug discovery. J. Comb. Chem. 2008, 10, 345-354.
9. Rishton, G. M. Reactive compounds and in vitro false positives in HTS. Drug Discov. Today 1997, 2, 382-384.
10. McGovern, S. L.; Helfand, B. T.; Feng, B.; Shoichet, B. K. A specific mechanism of nonspecific inhibition. J. Med. Chem. 2003, 46, 4265-4272.
11. Feng, B. Y.; Simeonov, A.; Jadhav, A.; Babaoglu, K.; Inglese, J.; Shoichet, B. K.; Austin, C. P. A High-throughput screen for aggregation-based inhibition in a large compound library. J. Med. Chem. 2007, 50, 2385-2390.
12. Shoichet, B. K. Interpreting steep dose-response curves in early inhibitor discovery. J. Med. Chem. 2006, 49, 7274-7277.
13. Babaoglu, K.; Simeonov, A.; Irwin, J. J.; Nelson, M. E.; Feng, B.; Thomas, C. J.; Cancian, L.; Costi, M. P.; Maltby, D. A.; Jadhav, A.; Inglese, J.; Austin, C. P.; Shoichet, B. K. Comprehensive mechanistic analysis of hits from high-throughput and docking screens against β-lactamase. J. Med. Chem. 2008, 51, 2502-2511.
14. Xia, M.; Huang, R.; Witt, K. L.; Southall, N.; Fostel, J.; Cho, M.-H.; Jadhav, A.; Smith, C. S.; Inglese, J.; Portier, C. J.; Tice, R. R.; Austin, C. P. Compound cytotoxicity profiling using quantitative high-throughput screening. Environ. Health Perspect. 2008, 3, 284-291.
15. Cho, M.-H.; Niles, A.; Huang, R.; Inglese, J.; Austin, C. P.; Riss, T.; Xia, M. A bioluminescent cytotoxicity assay for assessment of membrane integrity using a proteolytic biomarker. Toxicol. In Vitro 2008, 22, 1099-1106.
16. Huang, R.; Southall, N.; Cho M.-H.; Xia, M.; Inglese, J.; Austin, C. P. Characterization of diversity in toxicity mechanism using in vitro cytotoxicity assays in quantitative high throughput screening. Chem. Res. Toxicol. 2008, 21, 659-667.
17. Collins, F. S.; Gray, G. M.; Bucher, J. R. Tranforming environmental health protection. Science 2008, 319, 906-907.
18. Simeonov, A.; Jadhav, A.; Thomas, C. J.; Wang, Y.; Huang, R.; Southall, N. T.; Shinn, P.; Smith, J.; Austin, C. P.; Auld, D. S.; Inglese, J. Fluorescence spectroscopic profiling of compound libraries. J. Med. Chem. 2008, 51, 2363-2371.
19. Ahn, Y.-H.; Lee, J.-S.; Chang, Y.-T. J. Am. Chem. Soc. 2007, 129, 4510-4511.
20. Auld, D. S.; Southall, N. T.; Jadhav, A.; Johnson, R. L.; Diller, D. J.; Simeonov, A.; Austin C. P.; Inglese, J. Characterization of chemical libraries for luciferase inhibitory activity. J. Med. Chem. 2008, 51, 2372-2386.
21. http://pubchem.ncbi.nlm.nih.gov/
22. Thompson, J. F.; Hayes, L. S.; Lloyd, D. B. Modulation of firefly luciferase stability and impact on studies of gene regulation. Gene 1991, 103, 171-177.
23. Auld, D. S.; Thorne, N.; Nguyen, D.-T.; Inglese J. A specific mechanism for nonspecific activation in reporter-gene assays. ACS Chem. Biol. 2008, 3, 463-470.
24. Hruska, K. S.; LaMarca, M. E.; Sidransky, E. in Gaucher Disease; Futerman, A. H.; Zimran, A., Eds. CRC Press, Boca Raton FL. 2006, pp. 13-48.
25. Weinreb, N. J.; Charrow, J.; Andersson, H. C.; Kaplan, P.; Kolodny, E. H.; Mistry, P.; Pastores, G.; Rosenbloom, B. E.; Scoot, C. R.; Wappner, R. S.; Zimran, A. Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher registry. Am. J. Med. 1991, 113, 112-119.
26. Robben, J. H.; Sze, M.; Knoers, N. V. A. M.; Deen, P. M. T. Rescue of vasopressin V2 receptor mutants by chemical chaperones: specificity and mechanism. Mol. Biol. Cell. 2005, 17, 379-386.
27. Zheng, W.; Padia, J.; Urban, D. J.; Jadhav, A.; Goker-Alpann, O.; Simeonov, A.; Goldin, E.; Auld, D.; LeMarca, M. E.; Inglese, J.; Austin, C. P.; Sidransky, E. Proc. Natl. Acad. Sci. USA 2007, 104, 13192-13197.
28. Huang, W.; Zheng, W.; Urban, D. J.; Inglese, J.; Sidransky, E.; Austin, C. P.; Thomas, C. J. Bioorg. Med. Chem. Lett. 2007, 17, 5783-5789.
29. Titus, S.; Neumann, S.; Zheng, W.; Southall, N.; Michael, S.; Klumpp, C.; Yasgar, A.; Shinn, P.; Thomas, C. J.; Inglese, J.; Gershengorn, M. C.; Austin, C. P. Quantitative high-throughput screening using a live-cell cAMP assay identifies small-molecule agonists of the TSH receptor. J. Biomol. Screening 2008, 13, 120-127.
30. van Straten, N. C. R. Schoonus-Gerritsma, G. G.; van Someren, R. G.; Draaijer, J.; Adang, A. E. P.; Timmers, C. M.; Hanseen, R. G. J. M.; van Boeckel, C. A. A. The first orally active low molecular weight agonists for the LH receptor: Thienopyr(im)idines with therapeutic potential for ovulation induction. Chem. Biol. Chem. 2002, 3, 1023-1026.
31. Jäschke, H.; Neumann, S.; Moore, S.; Thomas, C. J.; Colson, A.-O.; Costanzi, S.; Kleinau, G.; Jiang, J.-K,; Paschke, R.; Raaka, B. M.; Krause, G.; Gershengorn, M. C. A low molecular weight agonist signals by binding to the transmembrane domain of thyroidstimulating hormone receptor (TSHR) and luteinizing hormone/chorionic gonadotropin receptor (LHCGR). J. Biol. Chem. 2006, 281, 9841-9844
32. Moore, S.; Jaeschke, H.; Kleinau, G.; Neumann, S.; Costanzi, S.; Jiang, J.-K.; Childress, J.; Raaka, B. M.; Colson, A.; Paschke, R.; Krause, G.; Thomas, C. J.; Gershengorn, M. C. Evaluation of small-molecule modulators of the luteinizing hormone/choriogonadotropin and thyroid stimulating hormone receptors: structure-activity relationships and selective binding patterns. J. Med. Chem. 2006, 49, 3888-3896.
33. Neumann, S.; Kleinau, G.; Costanzi, S.; Moore, S.; Jiang, J.-k.; Raaka, B. M.; Thomas, C. J.; Krause, G.; Gershengorn, M. C. A low molecular weight antagonist for the human thyrotropin receptor with therapeutic potential for hyperthyroidism. Endocrinology 2008, 149, 5945-5950.
34. Carlezon Jr., W. A.; Duman, R. S. ; Nestler, E. J. The many faces of CREB. Trends Neurosci. 2005, 28, 436-445.
35. Yin, J. C.; Del Vecchio, M.; Zhou, H.; Tully, T. CREB as a Memory Modulator: induced expression of a dCREB2 activator isoform enhances long-term memory in drosophila. Cell 1995, 81, 107-115.
36. Zhang, K. Y. J.; Ibrahim, P. N.; Gillette, S.; Bollag, G. Phosphodiesterase-4 as a potential drug target. Expert Opin. Ther. Targets 2005, 9, 1283-1303.
37. Jacob, J. N.; Nichols, D. E. Dopamine agonist properties of N-alkyl-4-(3,4-dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinolines. J. Med. Chem. 1981, 24, 1013.
38. Moreno, I.; Tellitu, I.; Dominguez, E.; SanMartin, R. A simple route to new phenanthro- and phenanthroid-Fused thiazoles by a PIFA-mediated (Hetero)biaryl coupling reaction. Eur. J. Org. Chem. 2002, 13, 2126.
39. Skoumbourdis, A. P.; Huang, R.; Southall, N.; Leister, W.; Guo, V.; Cho, M.-H.; Inglese, J.; Nirenberg, M.; Austin, C. P.; Xia, M.; Thomas, C. J. Identification of a potent new chemotype for the selective inhibition of PDE4. Bioorg. Med. Chem. Lett. 2008, 18, 1297-1303.
40. Hotez, P. J.; Brindley, P. J.; Bethony, J. M.; King, C. H.; Pearce, E. J.; Jacobson, J. Helminth infections: the great neglected tropical diseases. J. Clin. Invest. 2008, 118, 1311-1321.
41. Vermund, S. H.; Bradley, D. J.; Ruiz-Tiben, E. Survival of Schistosoma mansoni in the human host: estimates from a community-based prospective study in Puerto Rico. Am J. Tropical Med. Hyg. 1983, 32, 1040-1048.
42. Fallon, P. G.; Doenhoff, M. J. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drugs specific. Am. J. Trop. Med. Hyg. 1994, 51, 83-88.
43. Kuntz, A. N.; Davioud-Charvet, E.; Sayed, A. A.;Califf, L. L.; Dessolin, J.; Arnér, E. S.; Williams, D. L. Thioredoxin glutathione reductase from Schistosoma mansoini: an essential parasite enzyme and a key drug target. PLoS Med. 2007, 4, e260.
44. Simeonov, A.; Jadhav, A.; Sayed, A. A.; Wang, Y.; Nelson, M. E.; Thomas, C. J.; Inglese, J.; Williams, D. L.; Austin, C. P. Quantitative high-throughput screen identifies inhibitors of the Schistosoma mansoni redox cascade. PLoS Neg. Trop. Dis. 2008, 2, e127.
45. Lea, W. A.; Jadhav, A.; Rai, G.; Sayed, A. A. ; Cass, C. L.; Inglese, J.; Williams, D. L.; Austin, C. P.; Simeonov, A. A 1,536-well-based kinetic HTS assay for inhibitors of Schistosoma mansoni thioredoxin glutathione reductase. Assay Drug Dev. Tech. 2008, 6, 551-555.
46. Sayed, A. A.; Simeonov, A.; Thomas, C. J.; Inglese, J.; Austin, C. P.; Williams, D. L. Identification of oxadiazoles as new drug leads for the control of schistosomiasis. Nat. Med. 2008, 14, 407-412.
47. Medina, C.; Ermondi, G.; Fruttero, R.; Di Stilo, A.; Ferretti, C.; Gasco, A. Furoxans as nitric oxide donors. 4-phenyl-3-furoxancarbonitrile: thiol-mediated nitric oxide release and biological evaluation. J. Med. Chem. 1994, 37, 4412-4416.
48. 2-agonists: furoxan derivatives containing the fenterol moiety and related furazans. J. Med. Chem. 2007, 50, 5003-5011.
49. Turnbull, C. M.; Cena, C.; Fruttero, R.; Gasco, A.; Rossi, A. G.; Megson, I. L. Mechanism of action of NO-releasing furoxan derivatives of aspirin in human platelets. Br. J. Pharm. 2006, 148, 517-526.
50. 2-antagonists containing NO-donor moieties, endowed with mixed antisecretory and gastroprotective activities. Helv. Chem. Acta 2000, 83, 287-299.